ArticleClinical pharmacokinetics2023

Population Pharmacokinetics and Pharmacodynamics of Crizanlizumab in Healthy Subjects and Patients with Sickle Cell Disease.

Sherwin K B Sy et al.PubMed ↗Publisher ↗

No numbers read from the abstract.